Alterity Therapeutics Limited (ATHE)
NASDAQ: ATHE · Real-Time Price · USD
2.140
+0.060 (2.88%)
At close: Oct 27, 2026, 4:00 PM EDT
2.200
+0.060 (2.80%)
After-hours: Oct 27, 2026, 4:10 PM EDT
Alterity Therapeutics Market Cap
Alterity Therapeutics has a market cap or net worth of $38.67 million as of October 27, 2026. Its market cap has decreased by 44.03% in one year.
Market Cap
38.67M
Enterprise Value
12.56M
1-Year Change
-44.03%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since September 29, 2003, Alterity Therapeutics's market cap has increased from $29.20M to $38.67M, an increase of 32.44%. That is a compound annual growth rate of 1.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 38.67M | -17.54% |
| Dec 31, 2025 | 46.90M | 62.28% |
| Dec 31, 2024 | 28.90M | 186.14% |
| Dec 29, 2023 | 10.10M | -27.86% |
| Dec 30, 2022 | 14.00M | -44.00% |
| Dec 31, 2021 | 25.00M | 7.76% |
| Dec 31, 2020 | 23.20M | 107.14% |
| Dec 31, 2019 | 11.20M | -1.75% |
| Dec 31, 2018 | 11.40M | -58.99% |
| Dec 29, 2017 | 27.80M | 91.72% |
| Dec 30, 2016 | 14.50M | -62.53% |
| Dec 31, 2015 | 38.70M | -51.69% |
| Dec 31, 2014 | 80.10M | -70.06% |
| Dec 31, 2013 | 267.50M | 307.77% |
| Dec 31, 2012 | 65.60M | 61.98% |
| Dec 30, 2011 | 40.50M | 38.23% |
| Dec 31, 2010 | 29.30M | 9.33% |
| Dec 31, 2009 | 26.80M | -30.03% |
| Dec 31, 2008 | 38.30M | -36.80% |
| Dec 31, 2007 | 60.60M | 55.38% |
| Dec 29, 2006 | 39.00M | 95.98% |
| Dec 30, 2005 | 19.90M | -57.75% |
| Dec 31, 2004 | 47.10M | 43.60% |
| Dec 31, 2003 | 32.80M | 12.33% |
| Sep 29, 2003 | 29.20M | - |
View and export this data all the way back to 2003. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| LeonaBio | 44.85M |
| Elicio Therapeutics | 44.68M |
| Hyperion DeFi | 44.29M |
| Actinium Pharmaceuticals | 44.02M |
| Mereo BioPharma Group | 43.92M |
| Apollomics | 43.70M |
| Serina Therapeutics | 43.43M |
| Kalaris Therapeutics | 42.85M |